Share Price and Basic Stock Data
Last Updated: November 22, 2025, 11:30 am
| PEG Ratio | 0.65 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fluidomat Ltd operates in the engineering sector, with a reported market capitalization of ₹380 Cr and a current stock price of ₹770. Over the past year, the company has shown significant revenue growth, with sales reaching ₹45 Cr in FY 2023, an increase from ₹33 Cr in FY 2022. The quarterly sales figures reflect this upward trend, with the latest reported sales of ₹14.65 Cr in Sep 2023, up from ₹12.56 Cr in Jun 2023. This consistent growth trajectory is evident, as sales are projected to rise to ₹71 Cr by FY 2025, demonstrating a strong compound annual growth rate. The company’s operating profit margin (OPM) stood at 24.86%, indicating effective cost management relative to revenues. Furthermore, the cash conversion cycle (CCC) has stabilized at 147 days, suggesting a balanced approach to managing working capital. This combination of revenue growth and operational efficiency positions Fluidomat favourably within the general engineering industry, where competitive dynamics remain robust yet challenging.
Profitability and Efficiency Metrics
Fluidomat Ltd reported a net profit of ₹21 Cr for FY 2023, reflecting a significant increase compared to ₹10 Cr in FY 2022. This growth is underpinned by a profit margin of 20.82% for the same period, which is higher than the typical margins seen in the engineering sector. The return on equity (ROE) stood at an impressive 31.4%, indicating that the company is effectively generating profits from its equity base. Additionally, the return on capital employed (ROCE) was recorded at 42.2%, showcasing Fluidomat’s ability to generate substantial returns on its capital investments. Despite a cash conversion cycle of 147 days, the company maintains a high interest coverage ratio of 136101.00x, reflecting its strong financial health and ability to meet interest obligations comfortably. These metrics illustrate Fluidomat’s operational prowess and profitability, positioning it as a resilient player in the engineering landscape.
Balance Sheet Strength and Financial Ratios
Fluidomat’s balance sheet reflects a conservative financial structure, as the company reported no borrowings, which indicates a debt-free status. This is complemented by a price-to-book value (P/BV) ratio of 2.10x, suggesting that the stock is valued at a premium relative to its book value. The company’s cash earnings per share (EPS) reached ₹21.01 in FY 2023, up from ₹12.47 in FY 2022, reinforcing its strong earnings capacity. The current ratio of 2.74x and quick ratio of 2.07x indicate solid liquidity, providing reassurance to stakeholders regarding the company’s ability to cover short-term liabilities. Additionally, the dividend payout ratio has been maintained at 17.94%, reflecting a balanced approach to reinvestment and shareholder returns. Overall, Fluidomat’s strong financial ratios and absence of debt contribute to a robust balance sheet, enhancing its stability amid market fluctuations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fluidomat Ltd indicates a stable ownership structure, with promoters holding 53.45% of the shares as of Jun 2025, slightly declining from 53.59% in Mar 2023. This level of promoter ownership reflects confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) hold a modest 0.58% stake, which suggests limited foreign interest in the stock. Conversely, public shareholding has increased from 45.83% in Mar 2023 to 45.96% in Jun 2025, indicating growing retail investor participation. The total number of shareholders has also risen to 10,273, demonstrating enhanced market interest and confidence in Fluidomat’s growth story. While the stable promoter ownership is a positive aspect, the low FII participation may limit the stock’s liquidity and broader market appeal, posing a potential risk to investor sentiment.
Outlook, Risks, and Final Insight
Fluidomat Ltd’s outlook appears positive, driven by its strong revenue growth and profitability metrics. However, risks include its reliance on domestic markets, which may be susceptible to economic fluctuations, and the relatively low foreign institutional investment, which could impact liquidity. Additionally, maintaining operational efficiency amid rising costs remains a challenge. The company’s ability to innovate and adapt to market changes will be crucial for sustaining growth. If Fluidomat continues its trajectory of profitability and maintains its strong financial health, it could attract more institutional interest, enhancing its market presence. Conversely, any adverse economic conditions affecting the engineering sector could pose challenges. Overall, while Fluidomat has demonstrated resilience and strong fundamentals, vigilance regarding market dynamics and operational efficiency will be essential for its sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fluidomat Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 217 Cr. | 637 | 1,086/541 | 17.3 | 218 | 0.47 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 27.5 Cr. | 91.7 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 5.84 Cr. | 13.5 | 18.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.62 Cr. | 14.0 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 50.4 Cr. | 0.54 | 12.8/0.48 | 6.06 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,610.87 Cr | 466.54 | 53.55 | 118.97 | 0.28% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.91 | 13.03 | 9.92 | 14.29 | 12.56 | 14.65 | 12.63 | 15.65 | 15.59 | 19.00 | 16.64 | 20.95 | 12.39 |
| Expenses | 6.99 | 9.15 | 7.83 | 9.84 | 9.19 | 10.44 | 9.53 | 11.45 | 10.39 | 11.32 | 10.64 | 12.55 | 9.31 |
| Operating Profit | 1.92 | 3.88 | 2.09 | 4.45 | 3.37 | 4.21 | 3.10 | 4.20 | 5.20 | 7.68 | 6.00 | 8.40 | 3.08 |
| OPM % | 21.55% | 29.78% | 21.07% | 31.14% | 26.83% | 28.74% | 24.54% | 26.84% | 33.35% | 40.42% | 36.06% | 40.10% | 24.86% |
| Other Income | 0.35 | 0.39 | 0.36 | 0.17 | 0.59 | 0.70 | 0.58 | 1.58 | 0.67 | 0.76 | 1.33 | 0.70 | 0.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.20 | 0.20 | 0.20 | 0.14 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 | 0.23 | 0.23 | 0.27 | 0.29 |
| Profit before tax | 2.07 | 4.07 | 2.25 | 4.48 | 3.77 | 4.72 | 3.50 | 5.58 | 5.66 | 8.21 | 7.10 | 8.83 | 3.58 |
| Tax % | 25.12% | 25.06% | 24.00% | 26.34% | 26.53% | 25.21% | 25.43% | 25.63% | 25.09% | 24.73% | 23.66% | 27.63% | 25.14% |
| Net Profit | 1.55 | 3.05 | 1.71 | 3.30 | 2.77 | 3.52 | 2.61 | 4.15 | 4.24 | 6.17 | 5.42 | 6.39 | 2.68 |
| EPS in Rs | 3.15 | 6.19 | 3.47 | 6.70 | 5.62 | 7.14 | 5.30 | 8.42 | 8.61 | 12.52 | 11.00 | 12.97 | 5.44 |
Last Updated: August 19, 2025, 3:35 pm
Below is a detailed analysis of the quarterly data for Fluidomat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.39 Cr.. The value appears to be declining and may need further review. It has decreased from 20.95 Cr. (Mar 2025) to 12.39 Cr., marking a decrease of 8.56 Cr..
- For Expenses, as of Jun 2025, the value is 9.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.55 Cr. (Mar 2025) to 9.31 Cr., marking a decrease of 3.24 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.08 Cr.. The value appears to be declining and may need further review. It has decreased from 8.40 Cr. (Mar 2025) to 3.08 Cr., marking a decrease of 5.32 Cr..
- For OPM %, as of Jun 2025, the value is 24.86%. The value appears to be declining and may need further review. It has decreased from 40.10% (Mar 2025) to 24.86%, marking a decrease of 15.24%.
- For Other Income, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.70 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.09 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 3.58 Cr.. The value appears to be declining and may need further review. It has decreased from 8.83 Cr. (Mar 2025) to 3.58 Cr., marking a decrease of 5.25 Cr..
- For Tax %, as of Jun 2025, the value is 25.14%. The value appears to be improving (decreasing) as expected. It has decreased from 27.63% (Mar 2025) to 25.14%, marking a decrease of 2.49%.
- For Net Profit, as of Jun 2025, the value is 2.68 Cr.. The value appears to be declining and may need further review. It has decreased from 6.39 Cr. (Mar 2025) to 2.68 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.44. The value appears to be declining and may need further review. It has decreased from 12.97 (Mar 2025) to 5.44, marking a decrease of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:21 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28 | 28 | 27 | 26 | 24 | 27 | 25 | 28 | 33 | 45 | 55 | 71 | 69 |
| Expenses | 20 | 20 | 21 | 22 | 21 | 24 | 22 | 23 | 26 | 33 | 40 | 43 | 44 |
| Operating Profit | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 5 | 6 | 12 | 15 | 27 | 25 |
| OPM % | 30% | 28% | 21% | 15% | 12% | 11% | 13% | 17% | 19% | 27% | 27% | 39% | 36% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 3 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 8 | 8 | 6 | 4 | 3 | 3 | 4 | 5 | 7 | 13 | 18 | 30 | 28 |
| Tax % | 33% | 33% | 33% | 34% | 26% | 28% | 25% | 26% | 26% | 25% | 26% | 25% | |
| Net Profit | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 4 | 5 | 10 | 13 | 22 | 21 |
| EPS in Rs | 11.57 | 10.82 | 8.06 | 5.58 | 4.73 | 4.85 | 6.49 | 8.08 | 11.14 | 19.53 | 26.49 | 45.10 | 41.93 |
| Dividend Payout % | 24% | 25% | 31% | 31% | 37% | 41% | 35% | 40% | 31% | 23% | 17% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.67% | -20.00% | -25.00% | -33.33% | 0.00% | 50.00% | 33.33% | 25.00% | 100.00% | 30.00% | 69.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -3.33% | -5.00% | -8.33% | 33.33% | 50.00% | -16.67% | -8.33% | 75.00% | -70.00% | 39.23% |
Fluidomat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 23% |
| 3 Years: | 29% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 47% |
| 3 Years: | 62% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 59% |
| 3 Years: | 80% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 22% |
| 3 Years: | 26% |
| Last Year: | 31% |
Last Updated: September 5, 2025, 3:30 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 103 | 164 | 122 | 160 | 139 | 118 | 117 | 120 | 110 | 90 | 116 |
| Inventory Days | 155 | 212 | 223 | 165 | 181 | 142 | 214 | 189 | 141 | 141 | 113 | 84 |
| Days Payable | 72 | 89 | 75 | 58 | 92 | 79 | 118 | 123 | 137 | 91 | 70 | 53 |
| Cash Conversion Cycle | 170 | 225 | 312 | 228 | 249 | 202 | 214 | 183 | 124 | 159 | 132 | 147 |
| Working Capital Days | 64 | 94 | 164 | 133 | 185 | 169 | 171 | 159 | 146 | 90 | 150 | 155 |
| ROCE % | 45% | 35% | 23% | 15% | 10% | 11% | 13% | 15% | 18% | 29% | 32% | 42% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Diluted EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Cash EPS (Rs.) | 21.01 | 12.47 | 9.39 | 7.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Revenue From Operations / Share (Rs.) | 93.68 | 69.15 | 57.38 | 51.74 |
| PBDIT / Share (Rs.) | 27.62 | 15.73 | 12.30 | 10.01 |
| PBIT / Share (Rs.) | 26.12 | 14.38 | 11.00 | 8.66 |
| PBT / Share (Rs.) | 26.12 | 15.05 | 10.95 | 8.65 |
| Net Profit / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| NP After MI And SOA / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| PBDIT Margin (%) | 29.48 | 22.75 | 21.43 | 19.33 |
| PBIT Margin (%) | 27.88 | 20.79 | 19.16 | 16.74 |
| PBT Margin (%) | 27.88 | 21.76 | 19.08 | 16.72 |
| Net Profit Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| NP After MI And SOA Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| Return on Networth / Equity (%) | 19.53 | 13.25 | 10.72 | 9.73 |
| Return on Capital Employeed (%) | 25.54 | 16.69 | 14.21 | 12.66 |
| Return On Assets (%) | 16.03 | 10.69 | 8.87 | 7.77 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 |
| Asset Turnover Ratio (%) | 0.83 | 0.70 | 0.65 | 0.00 |
| Current Ratio (X) | 2.74 | 2.86 | 3.06 | 2.79 |
| Quick Ratio (X) | 2.07 | 2.32 | 2.25 | 2.05 |
| Inventory Turnover Ratio (X) | 3.10 | 2.36 | 1.90 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.94 | 29.23 | 0.00 | 30.88 |
| Dividend Payout Ratio (CP) (%) | 16.66 | 26.05 | 0.00 | 25.59 |
| Earning Retention Ratio (%) | 82.06 | 70.77 | 0.00 | 69.12 |
| Cash Earning Retention Ratio (%) | 83.34 | 73.95 | 0.00 | 74.41 |
| Interest Coverage Ratio (X) | 136101.00 | 2500.90 | 268.10 | 704.26 |
| Interest Coverage Ratio (Post Tax) (X) | 96208.00 | 1660.16 | 177.38 | 456.79 |
| Enterprise Value (Cr.) | 101.07 | 84.85 | 41.93 | 31.44 |
| EV / Net Operating Revenue (X) | 2.19 | 2.49 | 1.48 | 1.23 |
| EV / EBITDA (X) | 7.43 | 10.94 | 6.92 | 6.38 |
| MarketCap / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| Retention Ratios (%) | 82.05 | 70.76 | 0.00 | 69.11 |
| Price / BV (X) | 2.10 | 2.10 | 1.15 | 0.95 |
| Price / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| EarningsYield | 0.09 | 0.06 | 0.09 | 0.10 |
After reviewing the key financial ratios for Fluidomat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Diluted EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Cash EPS (Rs.), as of Mar 23, the value is 21.01. This value is within the healthy range. It has increased from 12.47 (Mar 22) to 21.01, marking an increase of 8.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 93.68. It has increased from 69.15 (Mar 22) to 93.68, marking an increase of 24.53.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 27.62. This value is within the healthy range. It has increased from 15.73 (Mar 22) to 27.62, marking an increase of 11.89.
- For PBIT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 14.38 (Mar 22) to 26.12, marking an increase of 11.74.
- For PBT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 15.05 (Mar 22) to 26.12, marking an increase of 11.07.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For PBDIT Margin (%), as of Mar 23, the value is 29.48. This value is within the healthy range. It has increased from 22.75 (Mar 22) to 29.48, marking an increase of 6.73.
- For PBIT Margin (%), as of Mar 23, the value is 27.88. This value exceeds the healthy maximum of 20. It has increased from 20.79 (Mar 22) to 27.88, marking an increase of 7.09.
- For PBT Margin (%), as of Mar 23, the value is 27.88. This value is within the healthy range. It has increased from 21.76 (Mar 22) to 27.88, marking an increase of 6.12.
- For Net Profit Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 10. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 20. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For Return on Networth / Equity (%), as of Mar 23, the value is 19.53. This value is within the healthy range. It has increased from 13.25 (Mar 22) to 19.53, marking an increase of 6.28.
- For Return on Capital Employeed (%), as of Mar 23, the value is 25.54. This value is within the healthy range. It has increased from 16.69 (Mar 22) to 25.54, marking an increase of 8.85.
- For Return On Assets (%), as of Mar 23, the value is 16.03. This value is within the healthy range. It has increased from 10.69 (Mar 22) to 16.03, marking an increase of 5.34.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.83. It has increased from 0.70 (Mar 22) to 0.83, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 23, the value is 2.74. This value is within the healthy range. It has decreased from 2.86 (Mar 22) to 2.74, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 23, the value is 2.07. This value exceeds the healthy maximum of 2. It has decreased from 2.32 (Mar 22) to 2.07, marking a decrease of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.10. This value is below the healthy minimum of 4. It has increased from 2.36 (Mar 22) to 3.10, marking an increase of 0.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 17.94. This value is below the healthy minimum of 20. It has decreased from 29.23 (Mar 22) to 17.94, marking a decrease of 11.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 16.66. This value is below the healthy minimum of 20. It has decreased from 26.05 (Mar 22) to 16.66, marking a decrease of 9.39.
- For Earning Retention Ratio (%), as of Mar 23, the value is 82.06. This value exceeds the healthy maximum of 70. It has increased from 70.77 (Mar 22) to 82.06, marking an increase of 11.29.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 83.34. This value exceeds the healthy maximum of 70. It has increased from 73.95 (Mar 22) to 83.34, marking an increase of 9.39.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 136,101.00. This value is within the healthy range. It has increased from 2,500.90 (Mar 22) to 136,101.00, marking an increase of 133,600.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 96,208.00. This value is within the healthy range. It has increased from 1,660.16 (Mar 22) to 96,208.00, marking an increase of 94,547.84.
- For Enterprise Value (Cr.), as of Mar 23, the value is 101.07. It has increased from 84.85 (Mar 22) to 101.07, marking an increase of 16.22.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.19. This value is within the healthy range. It has decreased from 2.49 (Mar 22) to 2.19, marking a decrease of 0.30.
- For EV / EBITDA (X), as of Mar 23, the value is 7.43. This value is within the healthy range. It has decreased from 10.94 (Mar 22) to 7.43, marking a decrease of 3.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 23, the value is 82.05. This value exceeds the healthy maximum of 70. It has increased from 70.76 (Mar 22) to 82.05, marking an increase of 11.29.
- For Price / BV (X), as of Mar 23, the value is 2.10. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.10.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For EarningsYield, as of Mar 23, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 22) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fluidomat Ltd:
- Net Profit Margin: 20.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.54% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.53% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 96208
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.8 (Industry average Stock P/E: 53.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | 117, 1st Floor, Navneet Darshan, Indore Madhya Pradesh 452018 | info@fluidomat.com http://www.fluidomat.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Jain | Chairman & Managing Director |
| Mrs. Radhica Sharma | Deputy Managing Director |
| Mr. Kunal Jain | Executive Director |
| Mr. Ashok Kumar Patni | Independent Director |
| Mr. Sharad Panot | Independent Director |
| Mr. Samyak Modi | Independent Director |